Enoxiluv Kit
Product Images NDC 76420-532

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Enoxiluv Kit (NDC 76420-532). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Asclemed Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Enoxaparin Figure A (Image 01)

An instructional illustration showing two hands holding a syringe and removing or attaching the syringe cap, with double-headed arrows indicating the direction of movement. The image depicts a step in the preparation or usage of the Enoxiluv Kit, which contains Enoxaparin Sodium and Isopropyl Alcohol for subcutaneous and topical administration.*

FDA Label Image

Enoxaparin Figure B (Image 02)

An instructional illustration showing a hand administering a subcutaneous injection with a syringe into the arm. The image highlights the injection technique, featuring a needle penetrating the skin with an arrow indicating direction.*

FDA Label Image

Enoxaparin Figure C (Image 03)

An instructional illustration showing a hand holding a syringe, positioned at an angle on a person's skin, indicating subcutaneous injection technique with an arrow pointing towards the skin.*

FDA Label Image

Enoxaparin Figure D (Image 04)

An illustration showing a hand holding a syringe with a plunger partially depressed, indicating preparation or use of the syringe. The image does not display any text or labeling.*

FDA Label Image

Enoxaparin Figure E (Image 05)

Illustration showing a gloved hand inserting a used syringe into a biohazard sharps disposal container, indicating proper disposal of medical sharps.*

FDA Label Image

Enoxaparin Sodium Chemical Structure (Image 06)

Chemical structure diagram of the active ingredients enoxaparin sodium and related polysaccharide components, illustrating the molecular substituents and variations in the polysaccharide chain for Enoxiluv Kit.*

FDA Label Image

Figure-1 (Image 07)

A forest plot depicting relative risk comparisons between Enoxaparin and UFH across various patient subgroups and conditions. The horizontal axis measures relative risk with confidence intervals indicated for factors such as sex, age groups, infarct location, diabetes status, and timing of treatment. The plot visually compares the efficacy and safety outcomes of Enoxaparin versus UFH in multiple clinical scenarios.*

FDA Label Image

Figure-2 (Image 08)

A line chart comparing the hazard distribution function over time (up to 30 days) for death or myocardial re-infarction between Enoxaparin and UFH. The chart shows Enoxaparin with a lower hazard function than UFH. A smaller inset graph presents similar data over one year. The graph includes a log-rank test with significant p-values and a table displaying the number of patients at risk over time for each treatment group.*

FDA Label Image

Principal Display Panel (Image 09)

Label for Enoxiluv Kit, a human prescription drug containing Enoxaparin Sodium Injection 40 mg/0.4 mL in single-dose syringes with an automatic safety device (ten 0.4 mL syringes). The kit also contains alcohol prep pads (70% isopropyl alcohol), powder-free sterile nitrile gloves (size M), adhesive bandages, and woven gauze single-use sponges. Distributed by Enovachem Pharmaceuticals, Torrance, CA.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.